Levonorgestrel-releasing intrauterine system: why do some women dislike it?

被引:21
|
作者
Daud, Suzanna [1 ]
Ewies, Ayman A. A. [1 ]
机构
[1] Ipswich Hosp NHS Trust, Dept Gynaecol, Ipswich IP4 5PD, Suffolk, England
关键词
Levonorgestrel-releasing intrauterine system; Mirena;
D O I
10.1080/09513590802444167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. There is growing evidence of women's dissatisfaction with the levonorgestrel-releasing intrauterine system (LNG-IUS) because of a high incidence of adverse effects. Objective. To quantify the continuation rate and users' satisfaction, and identify symptoms associated with early removal before the 5-years effective life-time. Method. A questionnaire was sent to 212 women, who had LNG-IUS inserted from 1 January 1998 to 31 December 2003 at The Ipswich Hospital, UK. Results. The response rate was 76% (n = 161), 16 of the respondents were excluded and the data of 145 are presented. The continuation rate was 85%, 70%, 59%, 56%, 50% and 50% at 6 months, 1, 2, 3, 4 and 5 years, respectively. The total number of women who had the LNG-IUS removed before 5 years was 72 (50%), and the median duration of use was 270 days (range 4-1460). The reasons for early removal were unscheduled bleeding, progestogenic adverse effects, abdominal pain and others in 40 (28%), 32 (22%), 19 (13%) and 19 (13%) women, respectively. Only 73 (50%) women were satisfied with LNG-IUS. Conclusions. Our findings are similar to recent reports, and this information should be readily available to women to enable them to make an informed choice.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 50 条
  • [31] Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia
    Luo, Li
    Luo, Bing
    Zheng, Ying
    Zhang, Heng
    Li, Jing
    Sidell, Neil
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [32] Profile of the levonorgestrel-releasing intrauterine system users in China
    Zhang Ying
    Bi Shiliang
    Zhao Shuping
    Wang Yan
    Qin Wen
    Deng Jihong
    Li Jian
    CHINESE MEDICAL JOURNAL, 2014, 127 (05) : 973 - 974
  • [33] Use of the levonorgestrel-releasing intrauterine system and breast cancer
    Backman, T
    Rauramo, I
    Jaakkola, K
    Inki, P
    Vaahtera, K
    Launonen, A
    Koskenvuo, M
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (04): : 813 - 817
  • [34] Use of the levonorgestrel-releasing intrauterine system and breast cancer
    Tjalma, WAA
    Trinh, XB
    van Dam, PA
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (01): : 207 - 208
  • [35] Body composition in users of levonorgestrel-releasing intrauterine system
    Dal'Ava, N.
    Bahamondes, L.
    Bahamondes, M. V.
    de Oliveira Santos, A.
    Monteiro, I.
    14TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2011, : 207 - 211
  • [36] The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders
    Schaedel, ZE
    Dolan, G
    Powell, MC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (04) : 1361 - 1363
  • [37] Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study
    Monteiro, I
    Bahamondes, L
    Diaz, J
    Perrotti, M
    Petta, C
    CONTRACEPTION, 2002, 65 (05) : 325 - 328
  • [38] Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
    Zgliczynska, Magdalena
    Kocaj, Karol
    Szymusik, Iwona
    Dutsch-Wicherek, Magdalena Maria
    Ciebiera, Michal
    Kosinska-Kaczynska, Katarzyna
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [39] Levonorgestrel-releasing intrauterine system and the risk of breast cancer
    Zurcher, Aline
    Stute, Petra
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2022, 20 (04): : 285 - 287
  • [40] Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system
    Li, Lei
    Leng, Jinhua
    Jia, Shuangzheng
    Lang, Jinghe
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 357 - 363